Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 19:43:100958.
doi: 10.1016/j.lanepe.2024.100958. eCollection 2024 Aug.

Cancer-preventing vaccination programs in prison: promoting health equity in Europe

Collaborators, Affiliations
Review

Cancer-preventing vaccination programs in prison: promoting health equity in Europe

Nicola Cocco et al. Lancet Reg Health Eur. .

Abstract

The most important human oncogenic viruses are hepatitis B virus (HBV) and human papillomavirus (HPV). The roll-out of vaccinations against HPV and HBV is a significant public health initiative with robust evidence of impact on the prevention of infection and neoplastic disease sequelae. Incarcerated individuals frequently have suboptimal immunisation levels for a wide variety of vaccine-preventable diseases, including HBV and HPV, and a high burden of disease for HBV/HPV-related cancers. In this Personal View, we analyse evidence regarding HBV and HPV vaccination in prison settings in 20 European countries and integrate it with existing scientific literature to discuss the rationale and possible strategies to expand cancer-preventing vaccination in prison populations. Enhancing HBV/HPV vaccination offer and uptake of HBV/HPV vaccination for this population would not only contribute to reducing the derived burden among the European population, but would also foster health equity and boost efforts towards the attainment of global and regional public health targets.

Keywords: Cancer prevention; Europe; HBV; HPV; Prison; Vaccination.

PubMed Disclaimer

Conflict of interest statement

MPTF, JM and AB received all support for the present manuscript and for attending meetings and/or travel from the RISE-Vac project co-funded by the European Union’s 3rd Health Programme. LT has received funding and grants from Italian public institutions and the EU and consulting fees from WHO Health in Prison Programme. Other authors declare no competing interests. The content of this manuscript represents the views of the authors only and is their sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Health and Digital Executive Agency (HaDEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.

References

    1. Beaudry G., Zhong S., Whiting D., Javid B., Frater J., Fazel S. Managing outbreaks of highly contagious diseases in prisons: a systematic review. BMJ Glob Health. 2020;5 - PMC - PubMed
    1. Vicente-Alcalde N., Ruescas-Escolano E., Harboe Z.B., Tuells J. Vaccination coverage among prisoners: a systematic review. Int J Environ Res Public Health. 2020;17:7589. - PMC - PubMed
    1. Moazen B., Saeedi Moghaddam S., Silbernagl M.A., et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40:58–69. - PubMed
    1. Bivegete S., McNaughton A.L., Trickey A., et al. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review. Euro Surveill. 2023;28 - PMC - PubMed
    1. WHO . WHO Regional Office for Europe; Copenhagen: 2022. Cancer and cardiovascular health inequities in prison settings: a rapid literature review.https://iris.who.int/bitstream/handle/10665/360079/WHO-EURO-2022-5814-45...

LinkOut - more resources